SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-015189
Filing Date
2019-10-08
Accepted
2019-10-07 21:47:08
Documents
12
Period of Report
2019-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44256
2 ex3-1.htm EX-3.1 6325
3 ex4-1.htm EX-4.1 80893
4 ex4-2.htm EX-4.2 62945
5 ex99-1.htm EX-99.1 15483
6 ex3-1_001.jpg GRAPHIC 86060
7 ex3-1_002.jpg GRAPHIC 91566
8 ex3-1_003.jpg GRAPHIC 108861
9 ex3-1_004.jpg GRAPHIC 93176
10 ex3-1_005.jpg GRAPHIC 94244
11 ex3-1_006.jpg GRAPHIC 241033
12 GRAPHIC ex99-1_001.jpg GRAPHIC 30095
  Complete submission text file 0001493152-19-015189.txt   1238221
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53723 | Film No.: 191141752
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences